Stock warrant tracker
Every outstanding warrant series recorded in a Signal8 dilution snapshot, one row per series: the shares it can be exercised into, the exercise price (strike), the expiry date, whether the price can reset after a later financing, and the SEC filing each figure was read from. Exercise prices and share counts are restated for every stock split since the filing, so they compare directly with the current share price.
5,300 warrant series at 1,050 companies. 779 in the money, 59 expiring in the next 30 days, 37 waiting on a stockholder vote or other stated condition, 3 becoming exercisable in the next 30 days.
Outstanding warrants
| Series | Shares | Exercise price | Last price | Vs strike | Expiry | Exercisable | Terms | Overhang | Source | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Consultant warrant (November 2021) — $1,768.00, exp. November 15, 2026 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Craft placement agent warrants — Fourth Tranche (September 26, 2025) — $3.256 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Craft placement agent warrants — Initial Tranche (June 25, 2025) — $4.20 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Craft placement agent warrants — Second Tranche (July 31, 2025) — $3.795 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Craft placement agent warrants — Third Tranche (August 21, 2025) — $3.52 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Investor relations warrants (August 2025) — $3.64 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Maxim placement agent warrants (August 9, 2023) — $83.64 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Maxim placement agent warrants (July 11, 2023) — $112.20 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Maxim placement agent warrants (July 19, 2023) — $81.60 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Maxim placement agent warrants (May 2024) — $15.90 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| May 2024 Series B common warrants (registered offering) — $14.45 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Note Offering Warrant (3i, December 10, 2025) — $2.231 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Investor Warrants — Fifth Tranche (June 17, 2026) | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Investor Warrants — Fourth Tranche (September 26, 2025) | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Investor Warrants — Initial Tranche (June 25, 2025) | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Investor Warrants — Second Tranche (July 31, 2025) | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Investor Warrants — Third Tranche (August 21, 2025) | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Warrant — Fifth Side Letter (November 6, 2026) — $0.5182 | $0.5434 | $1.2M | 8-K, Nov 9, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Warrant — First Side Letter (issued August 18, 2026) | $0.5434 | $1.2M | 424B3, Oct 21, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Warrant — Fourth Side Letter (October 26, 2026) — $1.0092 | $0.5434 | $1.2M | 8-K, Oct 27, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Warrant — Second Side Letter (August 31, 2026) — $3.62 | $0.5434 | $1.2M | 8-K, Sep 1, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series B Warrant — Third Side Letter (October 7, 2026) — $2.5520 | $0.5434 | $1.2M | 8-K, Oct 8, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series C Preferred Offering Warrants — Initial Tranche (December 10, 2025) — $2.231 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series C Warrant — Second Side Letter (August 31, 2026) — $3.62 | $0.5434 | $1.2M | 8-K, Sep 1, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| Series C Warrants — Fourth Side Letter (October 26, 2026) — $1.0092 | $0.5434 | $1.2M | 8-K, Oct 27, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| ThinkEquity IPO underwriter warrants — $10,625.00, exp. November 10, 2026 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| ThinkEquity representative's warrants (February 2023 offering) — $531.25 | $0.5434 | $1.2M | 10-Q, Aug 14, 2026Dilution tabAs of Nov 10, 2026 | ||||||||
| 2022 July Institutional/Accredited Investor Warrants | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2024 February Institutional/Accredited Investor Warrants - series A | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2024 February Institutional/Accredited Investor Warrants - series C | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2024 October Institutional/Accredited Investor Warrants | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2025 December 30 Institutional/Accredited Investor Warrants | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2025 July Institutional/Accredited Investor Warrants (Representative's Warrant) | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2025 May Institutional/Accredited Investor Warrants | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2026 April 13 Institutional/Accredited Investor Warrants | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2026 February Institutional/Accredited Investor Warrants | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2026 January Institutional/Accredited Investor Warrants | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2026 March 27 Institutional/Accredited Investor Warrants | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| 2026 March 6 Institutional/Accredited Investor Warrants | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 Consulting Warrants - May 18, 2025 1st Tranche ($720.00) | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 Consulting Warrants - May 18, 2025 2nd Tranche ($900.00) | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 Consulting Warrants - May 18, 2025 3rd Tranche ($1,080.00) | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 Consulting Warrants - May 7, 2025 1st Tranche ($756.00) | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 Consulting Warrants - May 7, 2025 2nd Tranche ($900.00) | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| May 2025 Consulting Warrants - May 7, 2025 3rd Tranche ($1,080.00) | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| November 2026 Series C AIR Warrants ($1.00) | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Underwriter Warrants - February 2024 offering | $0.6140 | $1.2M | 10-Q, Nov 13, 2026Dilution tabAs of Nov 14, 2026 | ||||||||
| Series A Warrants (September 20, 2024 unit offering) – remaining unexercised | $1.82 | $1.2M | 20-F, Sep 30, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| Series B Warrants (September 20, 2024 unit offering) – remaining unexercised | $1.82 | $1.2M | 20-F, Sep 30, 2026Dilution tabAs of Nov 12, 2026 | ||||||||
| August 2022 Placement Agent Options | $0.1897 | $1.2M | 10-Q, Nov 12, 2026Dilution tabAs of Nov 13, 2026 |
VBIOValion Bio, Inc.$0.5434Last price
Consultant warrant (November 2021) — $1,768.00, exp. November 15, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Craft placement agent warrants — Fourth Tranche (September 26, 2025) — $3.256
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Craft placement agent warrants — Initial Tranche (June 25, 2025) — $4.20
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Craft placement agent warrants — Second Tranche (July 31, 2025) — $3.795
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Craft placement agent warrants — Third Tranche (August 21, 2025) — $3.52
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Investor relations warrants (August 2025) — $3.64
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Maxim placement agent warrants (August 9, 2023) — $83.64
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Maxim placement agent warrants (July 11, 2023) — $112.20
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Maxim placement agent warrants (July 19, 2023) — $81.60
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Maxim placement agent warrants (May 2024) — $15.90
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
May 2024 Series B common warrants (registered offering) — $14.45
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Note Offering Warrant (3i, December 10, 2025) — $2.231
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Investor Warrants — Fifth Tranche (June 17, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Investor Warrants — Fourth Tranche (September 26, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Investor Warrants — Initial Tranche (June 25, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Investor Warrants — Second Tranche (July 31, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Investor Warrants — Third Tranche (August 21, 2025)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Warrant — Fifth Side Letter (November 6, 2026) — $0.5182
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Warrant — First Side Letter (issued August 18, 2026)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Warrant — Fourth Side Letter (October 26, 2026) — $1.0092
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Warrant — Second Side Letter (August 31, 2026) — $3.62
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series B Warrant — Third Side Letter (October 7, 2026) — $2.5520
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series C Preferred Offering Warrants — Initial Tranche (December 10, 2025) — $2.231
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series C Warrant — Second Side Letter (August 31, 2026) — $3.62
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
Series C Warrants — Fourth Side Letter (October 26, 2026) — $1.0092
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
ThinkEquity IPO underwriter warrants — $10,625.00, exp. November 10, 2026
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
VBIOValion Bio, Inc.$0.5434Last price
ThinkEquity representative's warrants (February 2023 offering) — $531.25
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2022 July Institutional/Accredited Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2024 February Institutional/Accredited Investor Warrants - series A
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2024 February Institutional/Accredited Investor Warrants - series C
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2024 October Institutional/Accredited Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2025 December 30 Institutional/Accredited Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2025 July Institutional/Accredited Investor Warrants (Representative's Warrant)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2025 May Institutional/Accredited Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2026 April 13 Institutional/Accredited Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2026 February Institutional/Accredited Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2026 January Institutional/Accredited Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2026 March 27 Institutional/Accredited Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
2026 March 6 Institutional/Accredited Investor Warrants
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
May 2025 Consulting Warrants - May 18, 2025 1st Tranche ($720.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
May 2025 Consulting Warrants - May 18, 2025 2nd Tranche ($900.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
May 2025 Consulting Warrants - May 18, 2025 3rd Tranche ($1,080.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
May 2025 Consulting Warrants - May 7, 2025 1st Tranche ($756.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
May 2025 Consulting Warrants - May 7, 2025 2nd Tranche ($900.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
May 2025 Consulting Warrants - May 7, 2025 3rd Tranche ($1,080.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
November 2026 Series C AIR Warrants ($1.00)
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
NVVENuvve Holding Corp.$0.6140Last price
Underwriter Warrants - February 2024 offering
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
HAOHaoxi Health Technology Limited Class A Ordinary Shares$1.82Last price
Series A Warrants (September 20, 2024 unit offering) – remaining unexercised
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
HAOHaoxi Health Technology Limited Class A Ordinary Shares$1.82Last price
Series B Warrants (September 20, 2024 unit offering) – remaining unexercised
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
RKDAArcadia Biosciences, Inc.$0.1897Last price
August 2022 Placement Agent Options
- Shares
- Exercise price
- Expiry
- Exercisable
- Terms
- Overhang
- Mkt cap$1.2M
Source: SEC filings cited in each company’s dilution snapshot, compiled by Signal8, as of November 17, 2026.
Read from 2,061 dilution snapshots. 4,846 of 5,300 series state an exercise price and 3,366 an expiry date. 98 record when exercise begins; that count grows as companies are re-extracted. 633 series are left off because their figures could not be restated for a stock split. 20 companies and 0 series are held back pending review. Share counts, exercise prices, expiry dates and terms are included in Signal8 Pro. Not investment advice.
About this list
Most of the companies listed are small caps and penny stocks, where warrants are routinely issued with registered direct offerings, PIPEs and underwritten unit deals. When a warrant is exercised the company issues new shares, so the list is a record of shares that do not exist yet but can be issued.
Coverage is limited to the companies Signal8 has a dilution snapshot for. A company that is not listed may still have warrants outstanding, and a figure shown as Not stated was not found in the filings read, which is not a statement that it is zero.
The date a warrant first becomes exercisable is recorded only for companies extracted since Signal8 started reading it. Not recorded yet means the snapshot predates that field, not that the warrant is exercisable. Coverage grows as companies are re-extracted.
Frequently asked questions
- What is a stock warrant?
- A warrant gives its holder the right to buy new shares from the company at a fixed exercise price until an expiry date. When warrants are exercised the company issues new shares, which adds to the share count. Unlike an exchange-listed option, a warrant is issued by the company itself, usually alongside a financing.
- What does in the money mean for a warrant?
- A warrant is in the money when the current share price is above its exercise price, so exercising it costs less than buying the shares on the market. This page compares the last price with the exercise price after restating both for any stock split, and says No recent price when there is no price from the last 7 days.
- Which warrants are expiring soon?
- Each row shows the expiry date stated in the filing, and series that expire within 30 days are marked. A warrant that is not exercised by its expiry date lapses and no shares are issued for it. A row whose stated date has passed says so; the filing record does not show whether that series was exercised before it lapsed.
- What is a warrant exercise price reset or full ratchet?
- Some warrants lower their exercise price if the company later sells shares more cheaply. A full ratchet resets it to the new lower price; a weighted-average adjustment moves it part of the way; some warrants reset on a set date to a price tied to the market. A lower exercise price can also raise the number of shares the warrant covers. The Terms column shows the adjustment the filing describes.
- What is a pre-funded warrant?
- A pre-funded warrant is one where the buyer has already paid almost the whole price up front, leaving a nominal exercise price such as $0.0001 per share. It is in the money by construction, so this page marks it as such and does not rank it by distance from the strike.
- Why are exercise prices split-adjusted?
- Filings state exercise prices and share counts as of their filing date. After a reverse split a warrant covers fewer shares at a higher price. Signal8 restates both onto the current share basis; a series whose basis cannot be resolved is left off the page and counted under the table, rather than shown as filed.
- What is warrant overhang?
- Overhang is the number of shares the warrants can be exercised into, shown here as a percentage of shares outstanding, with both figures on the same split basis. Not measured means one of the two figures is missing.
- Where does the data come from and how often is it updated?
- Each row is read from the SEC filings cited in that company’s Signal8 dilution snapshot, and the source filing link on every row opens the document the figures were taken from. The list is rebuilt from the latest snapshots at least every 30 minutes, and each row shows the date of the snapshot it was read from.
Related
- PIPE tracker: private placements and registered directs
- Pending S-1 filings: offerings not yet effective
- Reverse split calendar
- Recently delisted stocks
- High dilution scanner
- Stock dilution checker
- Warrant overhang: how to count shares not issued yet
- Warrant price resets and ratchets explained
- Warrant inducements explained
- Warrants vs options
- How to read the Signal8 dilution tab
Not investment advice.